AVXL - アナベックス・ライフ・サイエンシズ (Anavex Life Sciences Corp.) アナベックス・ライフ・サイエンシズ

 AVXLのチャート


 AVXLの企業情報

symbol AVXL
会社名 Anavex Life Sciences Corp (アナベックス・ライフ・サイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アナヴェックス・ライフ・サイエンス(Anavex Life Sciences Corp.)は臨床段階のバイオ医薬品会社である。同社は神経変性疾患および神経発達疾患の治療用の差別化された治療薬の開発に従事する。その治療薬はアルツハイマー病(AD)、他の中枢神経系(CNS)疾患、疼痛および各種類の癌を治療するための薬物候補を含む。その研究開発パイプラインには、前臨床試験の各段階における臨床薬候補と多様な化合物が含まれる。製品パイプラインには、ANAVEX 2-73、ANAVEX 3-71、ANAVEX 1-41、ANAVEX 1037およびANAVEX 1066が含まれる。SIGMACEPTORディスカバリープラットフォームは、シグマ受容体の理解に基づいて、作用機序を有する小分子薬物候補を産生する。ANAVEX 1-41はシグマ-1アゴニストである。ANAVEX 1066は混合シグマ-1 /シグマ-2リガンドである。同社は事業から収入を得ていない。   アナベックス・ライフ・サイエンシズは米国の臨床段階のバイオ医薬品会社。アルツハイマ―病、中枢神経系疾患、前立腺がん、膵臓がんなどに焦点を当て、新しい候補薬の研究・開発を行う。シグマ受容体の働きに基づいて開発された、同社の「シグマセプタ―・ディスカバリ―・プラットフォ―ム」は、独特な方法により小分子候補薬を生産する。本社はニューヨーク。   Anavex Life Sciences Corp. is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, Parkinson's disease, Rett syndrome and other central nervous system (CNS) diseases, pain and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), recently completed a successful Phase 2a clinical trial for Alzheimer's disease. ANAVEX®2-73 (blarcamesine) is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer's disease. ANAVEX®2-73 (blarcamesine) also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The Michael J. Fox Foundation for Parkinson's Research previously awarded Anavex a research grant, which fully funded a preclinical study to develop ANAVEX®2-73 (blarcamesine) for the treatment of Parkinson's disease. ANAVEX®3-71, which targets sigma-1 and muscarinic receptors, is a promising preclinical drug candidate demonstrating disease-modifying activity against the major hallmarks of Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies. In preclinical trials, ANAVEX®3-71 has shown beneficial effects on mitochondrial dysfunction and neuroinflammation.
本社所在地 51 West 52nd Street 7th Floor New York NY 10019 USA
代表者氏名 Christopher U. Missling クリストファー・ミッシング
代表者役職名 President Chief Executive Officer Secretary Director
電話番号 +1 800-689-3939
設立年月日 37987
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 10人
url www.anavex.com
nasdaq_url https://www.nasdaq.com/symbol/avxl
adr_tso
EBITDA EBITDA(百万ドル) -18.64204
終値(lastsale) 2.48
時価総額(marketcap) 112669636.4
時価総額 時価総額(百万ドル) 117.66710
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 91.83951
当期純利益 当期純利益(百万ドル) -16.81492
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Anavex Life Sciences Corp revenues was not reported. Net loss increased 40% to $11.7M. Higher net loss reflects Research and development - Balancing val increase of 88% to $6.9M (expense) General and administrative - Balancing increase of 68% to $2.5M (expense) Stock-based Compensation in SGA increase of 95% to $2M (expense).

 AVXLのテクニカル分析


 AVXLのニュース

   Bonawyn Eison Sees Unusual Options Activity In Anavex Life Sciences  2021/02/05 12:55:00 Benzinga
On CNBC's "Options Action," Bonawyn Eison spoke about unusually high options volume in Anavex Life Sciences Corp (NASDAQ: AVXL), as around …
   The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street  2021/02/05 12:43:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 4) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agenus Inc (NASDAQ: AGEN ) (announced positive preliminary results from its Phase 1 trial of iNKT cell therapy in patients with moderate to severe symptoms of COVID-19) Anavex Life Sciences Corp (NASDAQ: AVXL ) AngioDynamics, Inc. (NASDAQ: ANGO ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) BioVie Inc (NASDAQ: BIVI ) Cassava Sciences Inc (NASDAQ: SAVA ) Castle Biosciences Inc (NASDAQ: CSTL ) (announced new data on validity and accuracy of skin cancer diagnostics test in patients with T1 cutaneous melanoma tumors) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) ChemoCentryx Inc (NASDAQ: CCXI ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) CorMedix Inc. Common Stock (NASDAQ: CRMD ) DermTech Inc (NASDAQ: DMTK ) Evogene Ltd (NASDAQ: EVGN ) F-Star Therapeutics Inc (NASDAQ: FSTX ) Glaukos Corp (NYSE: GKOS ) Gracell Biotechnologies Inc (NASDAQ: GRCL ) Halozyme Therapeutics, Inc.
   Here Are The Companies WallStreetBets May Target Next  2021/02/04 18:30:00 Zero Hedge
Here Are The Companies WallStreetBets May Target Next With Gamestop stock in freefall, down more than 85% from its all time highs and dragging many of the other most shorted "meme" stocks that soared at the end of January… ... the question on every trader's mind is whether the squeeze (and hedge fund deleveraging) is finally over and is it safe to go back to shorting again? Addressing this point, JPM strategists published a report overnight in which they note that the most common questions people are asking are “does the de-risking persist?” or“what do we expect going forward? ” As JPM explains, it seems likely that we’re through most of the extreme deleveraging, especially among L/S funds, given how much L/S funds de-grossed last week and how negative alpha spreads were. Validating this point, the strategists point to the improving HF returns that are getting reported in the press so far which suggest that there were bright spots within L/S last month, while other strategies generally held up better than L/S.
   4 Penny Stocks on the Move: Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSE: IBIO), Solar Integrated Roofing (OTC US: SIRC), and Tesoro Enterprises (OTC US: TSNP) - Stocks News Feed  2021/02/04 14:38:38 Stocks News Feed
If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT: IBIO), Solar Integrated Roofing (OTCMKTS: SIRC), and Tesoro Enterprises (OTCMKTS: TSNP). HOW TO TRADE PENNY STOCKS… Read More »4 Penny Stocks on the Move: Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSE: IBIO), Solar Integrated Roofing (OTC US: SIRC), and Tesoro Enterprises (OTC US: TSNP)
   Penny Stocks Are Soaring In The Pre-Market  2021/02/04 14:11:10 Zero Hedge
Penny Stocks Are Soaring In The Pre-Market It appears we were right when we suggested last week that after the Reddit-Raiders were done with squeezing shorts, they would transition to penny-stock-pumping. What's after the short squeeze slaughter: the pennystock pump? — zerohedge (@zerohedge) January 30, 2021 As Micro-Cap stocks have surged in recent days… Today's advance in the pre-market is dominated by a handful of biotech penny-stocks. Anavex Life Sciences, VTv Therapeutics and Cassava Sciences, all drug developers racing to come up with treatments for Alzheimer’s disease, were among the top performers. Along with Cassava, biotechs picking up steam on Reddit also included Covid-19 plays such as Tonix Pharmaceuticals and Atossa Therapeutics. Their shares traded in the millions during the early morning session. Additionally, Bloomberg notes that companies with low float compared to shares outstanding are soaring , such as Profire Energy +57% and DavidsTea +24%. So, will Penny-Stocks be the next 'GameStop'?
   Bonawyn Eison Sees Unusual Options Activity In Anavex Life Sciences  2021/02/05 12:55:00 Benzinga
On CNBC's "Options Action," Bonawyn Eison spoke about unusually high options volume in Anavex Life Sciences Corp (NASDAQ: AVXL), as around …
   The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street  2021/02/05 12:43:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 4) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agenus Inc (NASDAQ: AGEN ) (announced positive preliminary results from its Phase 1 trial of iNKT cell therapy in patients with moderate to severe symptoms of COVID-19) Anavex Life Sciences Corp (NASDAQ: AVXL ) AngioDynamics, Inc. (NASDAQ: ANGO ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) BioVie Inc (NASDAQ: BIVI ) Cassava Sciences Inc (NASDAQ: SAVA ) Castle Biosciences Inc (NASDAQ: CSTL ) (announced new data on validity and accuracy of skin cancer diagnostics test in patients with T1 cutaneous melanoma tumors) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) ChemoCentryx Inc (NASDAQ: CCXI ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) CorMedix Inc. Common Stock (NASDAQ: CRMD ) DermTech Inc (NASDAQ: DMTK ) Evogene Ltd (NASDAQ: EVGN ) F-Star Therapeutics Inc (NASDAQ: FSTX ) Glaukos Corp (NYSE: GKOS ) Gracell Biotechnologies Inc (NASDAQ: GRCL ) Halozyme Therapeutics, Inc.
   Here Are The Companies WallStreetBets May Target Next  2021/02/04 18:30:00 Zero Hedge
Here Are The Companies WallStreetBets May Target Next With Gamestop stock in freefall, down more than 85% from its all time highs and dragging many of the other most shorted "meme" stocks that soared at the end of January… ... the question on every trader's mind is whether the squeeze (and hedge fund deleveraging) is finally over and is it safe to go back to shorting again? Addressing this point, JPM strategists published a report overnight in which they note that the most common questions people are asking are “does the de-risking persist?” or“what do we expect going forward? ” As JPM explains, it seems likely that we’re through most of the extreme deleveraging, especially among L/S funds, given how much L/S funds de-grossed last week and how negative alpha spreads were. Validating this point, the strategists point to the improving HF returns that are getting reported in the press so far which suggest that there were bright spots within L/S last month, while other strategies generally held up better than L/S.
   4 Penny Stocks on the Move: Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSE: IBIO), Solar Integrated Roofing (OTC US: SIRC), and Tesoro Enterprises (OTC US: TSNP) - Stocks News Feed  2021/02/04 14:38:38 Stocks News Feed
If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT: IBIO), Solar Integrated Roofing (OTCMKTS: SIRC), and Tesoro Enterprises (OTCMKTS: TSNP). HOW TO TRADE PENNY STOCKS… Read More »4 Penny Stocks on the Move: Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSE: IBIO), Solar Integrated Roofing (OTC US: SIRC), and Tesoro Enterprises (OTC US: TSNP)
   Penny Stocks Are Soaring In The Pre-Market  2021/02/04 14:11:10 Zero Hedge
Penny Stocks Are Soaring In The Pre-Market It appears we were right when we suggested last week that after the Reddit-Raiders were done with squeezing shorts, they would transition to penny-stock-pumping. What's after the short squeeze slaughter: the pennystock pump? — zerohedge (@zerohedge) January 30, 2021 As Micro-Cap stocks have surged in recent days… Today's advance in the pre-market is dominated by a handful of biotech penny-stocks. Anavex Life Sciences, VTv Therapeutics and Cassava Sciences, all drug developers racing to come up with treatments for Alzheimer’s disease, were among the top performers. Along with Cassava, biotechs picking up steam on Reddit also included Covid-19 plays such as Tonix Pharmaceuticals and Atossa Therapeutics. Their shares traded in the millions during the early morning session. Additionally, Bloomberg notes that companies with low float compared to shares outstanding are soaring , such as Profire Energy +57% and DavidsTea +24%. So, will Penny-Stocks be the next 'GameStop'?
   Bonawyn Eison Sees Unusual Options Activity In Anavex Life Sciences  2021/02/05 12:55:00 Benzinga
On CNBC's "Options Action," Bonawyn Eison spoke about unusually high options volume in Anavex Life Sciences Corp (NASDAQ: AVXL), as around …
   The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street  2021/02/05 12:43:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 4) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agenus Inc (NASDAQ: AGEN ) (announced positive preliminary results from its Phase 1 trial of iNKT cell therapy in patients with moderate to severe symptoms of COVID-19) Anavex Life Sciences Corp (NASDAQ: AVXL ) AngioDynamics, Inc. (NASDAQ: ANGO ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) BioVie Inc (NASDAQ: BIVI ) Cassava Sciences Inc (NASDAQ: SAVA ) Castle Biosciences Inc (NASDAQ: CSTL ) (announced new data on validity and accuracy of skin cancer diagnostics test in patients with T1 cutaneous melanoma tumors) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) ChemoCentryx Inc (NASDAQ: CCXI ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) CorMedix Inc. Common Stock (NASDAQ: CRMD ) DermTech Inc (NASDAQ: DMTK ) Evogene Ltd (NASDAQ: EVGN ) F-Star Therapeutics Inc (NASDAQ: FSTX ) Glaukos Corp (NYSE: GKOS ) Gracell Biotechnologies Inc (NASDAQ: GRCL ) Halozyme Therapeutics, Inc.
   Here Are The Companies WallStreetBets May Target Next  2021/02/04 18:30:00 Zero Hedge
Here Are The Companies WallStreetBets May Target Next With Gamestop stock in freefall, down more than 85% from its all time highs and dragging many of the other most shorted "meme" stocks that soared at the end of January… ... the question on every trader's mind is whether the squeeze (and hedge fund deleveraging) is finally over and is it safe to go back to shorting again? Addressing this point, JPM strategists published a report overnight in which they note that the most common questions people are asking are “does the de-risking persist?” or“what do we expect going forward? ” As JPM explains, it seems likely that we’re through most of the extreme deleveraging, especially among L/S funds, given how much L/S funds de-grossed last week and how negative alpha spreads were. Validating this point, the strategists point to the improving HF returns that are getting reported in the press so far which suggest that there were bright spots within L/S last month, while other strategies generally held up better than L/S.
   4 Penny Stocks on the Move: Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSE: IBIO), Solar Integrated Roofing (OTC US: SIRC), and Tesoro Enterprises (OTC US: TSNP) - Stocks News Feed  2021/02/04 14:38:38 Stocks News Feed
If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT: IBIO), Solar Integrated Roofing (OTCMKTS: SIRC), and Tesoro Enterprises (OTCMKTS: TSNP). HOW TO TRADE PENNY STOCKS… Read More »4 Penny Stocks on the Move: Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSE: IBIO), Solar Integrated Roofing (OTC US: SIRC), and Tesoro Enterprises (OTC US: TSNP)
   Penny Stocks Are Soaring In The Pre-Market  2021/02/04 14:11:10 Zero Hedge
Penny Stocks Are Soaring In The Pre-Market It appears we were right when we suggested last week that after the Reddit-Raiders were done with squeezing shorts, they would transition to penny-stock-pumping. What's after the short squeeze slaughter: the pennystock pump? — zerohedge (@zerohedge) January 30, 2021 As Micro-Cap stocks have surged in recent days… Today's advance in the pre-market is dominated by a handful of biotech penny-stocks. Anavex Life Sciences, VTv Therapeutics and Cassava Sciences, all drug developers racing to come up with treatments for Alzheimer’s disease, were among the top performers. Along with Cassava, biotechs picking up steam on Reddit also included Covid-19 plays such as Tonix Pharmaceuticals and Atossa Therapeutics. Their shares traded in the millions during the early morning session. Additionally, Bloomberg notes that companies with low float compared to shares outstanding are soaring , such as Profire Energy +57% and DavidsTea +24%. So, will Penny-Stocks be the next 'GameStop'?

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アナベックス・ライフ・サイエンシズ AVXL Anavex Life Sciences Corp.)

 twitter  (公式ツイッターやCEOツイッターなど)